Chinese import law postponed
This article was originally published in The Gray Sheet
China's government indefinitely postpones implementation of regulations that U.S. manufacturers say would otherwise delay device imports into China. Decree 95, or Administrative Measures on Examination and Supervision of Imported Medical Devices, was originally scheduled to take effect Dec. 1 (1"The Gray Sheet" Nov. 5, 2007, p. 3). Though China's Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) states that the implementation deadline will be "subsequently announced," an AdvaMed spokesperson says that "this type of indefinite suspension generally means Decree 95 is dead, unless AQSIQ re-initiates the rulemaking process at some future date.
You may also be interested in...
U.S. officials with the World Trade Organization and the U.S. device industry are challenging China's government on pending regulations they say will create unnecessary delays in getting devices into China and onto its market
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.